GeneTether Therapeutics Inc. (CSE: GTTX)

GeneTether Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 29, 2024	Dec 30, 2023	Dec 30, 2022	Dec 30, 2021	Dec 30, 2020	Dec 30, 2019
Cash & Equivalents	0.97	1.36	1.8	0.18	0.05	0.01
Cash & Short-Term Investments	0.97	1.36	1.8	0.18	0.05	0.01
Cash Growth	-29.04%	-24.06%	898.49%	296.21%	348.86%	-60.46%
Prepaid Expenses	0.05	0.05	0.15	-	-	0
Other Current Assets	-	-	-	0.19	-	0
Total Current Assets	1.02	1.41	1.94	0.37	0.05	0.01
Total Assets	1.02	1.41	1.94	0.37	0.05	0.01
Accounts Payable	0.03	0.03	0.06	0.21	0	0
Short-Term Debt	-	-	-	-	0.12	0.02
Other Current Liabilities	-	0.01	0.02	-	-	-
Total Current Liabilities	0.03	0.04	0.09	0.21	0.12	0.02
Total Liabilities	0.03	0.04	0.09	0.21	0.12	0.02
Common Stock	4.2	4.2	4.18	1.25	0.16	0
Additional Paid-In Capital	1.66	1.63	1.48	0.79	-	0.16
Retained Earnings	-4.66	-4.28	-3.59	-1.88	-0.24	-0.17
Comprehensive Income & Other	-0.21	-0.17	-0.2	-	-0	-
Shareholders' Equity	0.99	1.37	1.86	0.16	-0.08	-0.01
Total Liabilities & Equity	1.02	1.41	1.94	0.37	0.05	0.01
Total Debt	-	-	-	-	0.12	0.02
Net Cash (Debt)	0.97	1.36	1.8	0.18	-0.08	-0.01
Net Cash Growth	-29.04%	-24.06%	898.49%	-	-	-
Net Cash Per Share	0.02	0.03	0.04	0.01	-0.00	-0.01
Filing Date Shares Outstanding	38.74	38.74	48.38	47.85	0.79	0.72
Total Common Shares Outstanding	38.74	38.74	48.38	38.51	0.79	0.72
Working Capital	0.99	1.37	1.86	0.16	-0.08	-0.01
Book Value Per Share	0.03	0.04	0.04	0.00	-0.10	-0.01
Tangible Book Value	0.99	1.37	1.86	0.16	-0.08	-0.01
Tangible Book Value Per Share	0.03	0.04	0.04	0.00	-0.10	-0.01

Source: S&P Capital IQ. Standard template. Financial Sources.